A Clinical Study to Evaluate the Pharmacokinetics and Bioequivalence of HMPL-523 Tablets Produced by Two Different Manufacturers
NCT05318820
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
39
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subject
Interventions
DRUG:
HMPL-523
Sponsor
Hutchison Medipharma Limited